Cargando…
A novel pan‐cancer biomarker plasma heat shock protein 90alpha and its diagnosis determinants in clinic
A sensitive and specific diagnosis biomarker, in principle scalable to most cancer types, is needed to reduce the prevalent cancer mortality. Meanwhile, the investigation of diagnosis determinants of a biomarker will facilitate the interpretation of its screening results in clinic. Here we design a...
Autores principales: | Liu, Wei, Li, Jie, Zhang, Ping, Hou, Qiaoyun, Feng, Shi, Liu, Lisheng, Cui, Dawei, Shi, Hubing, Fu, Yan, Luo, Yongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726694/ https://www.ncbi.nlm.nih.gov/pubmed/31343810 http://dx.doi.org/10.1111/cas.14143 |
Ejemplares similares
-
Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial
por: Fu, Yan, et al.
Publicado: (2017) -
Extracellular Heat Shock Protein-90 (eHsp90): Everything You Need to Know
por: Jay, Daniel, et al.
Publicado: (2022) -
Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics
por: Han, Yueting, et al.
Publicado: (2021) -
Plasma Levels of Heat Shock Protein 90 Alpha Associated With Colorectal Cancer Development
por: Wei, Wene, et al.
Publicado: (2021) -
Comprehensive Pan-Cancer Analysis of Heat Shock Protein 110, 90, 70, and 60 Families
por: Yan, Li-rong, et al.
Publicado: (2021)